期刊文献+

miRNA-1对胃癌细胞体外EGFR-TKI敏感性影响的实验研究 被引量:2

Effect of miRNA-1 on EGFR-TKI sensitivity of gastric cancer cells in vitro
下载PDF
导出
摘要 目的探讨上调或沉默miRNA-1(miR-1)表达对胃癌细胞体外表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)敏感性影响的研究。方法选择人胃癌细胞系MKN-45作为受试对象,慢病毒转染miR-1或miR-1 shRNA,分别作为miR-1组和miR-1 shRNA组,并采用实时荧光定量PCR(qPCR)法检测GES-1和MKN-45细胞中miR-1表达。另外设置空白对照组和阴性对照组。采用MTT法检测MKN-45细胞对不同浓度AZD9291(奥西替尼)的敏感性;流式细胞术检测1μmol/L AZD9291作用48 h后MKN-45细胞凋亡活力和细胞周期。采用Western blotting法检测各组细胞中PI3K/AKT通路相关蛋白的表达。结果qPCR证实miR-1在MKN-45细胞系中低表达。MTT法检测结果显示,与空白对照组比较,miR-1组细胞对AZD9291敏感性明显增加,而miR-1 shRNA组细胞对AZD9291敏感性明显降低。Annexin V/PI双染法和BrdU法检测,miR-1组细胞凋亡率为(44.65±5.18)%,高于空白对照组的(15.40±2.13)%和阴性对照组的(17.92±3.14)%,差异有统计学意义(P<0.05)。miR-1 shRNA组细胞凋亡率为(11.20±2.48)%,低于空白对照组和阴性对照组,差异有统计学意义(P<0.05)。与空白对照组和阴性对照组比较,miR-1组细胞IGF-1R、p-IGF-1R、p-AKT、p-p70S6K蛋白表达量明显降低,miR-1 shRNA组细胞IGF-1R、p-IGF-1R、p-AKT、p-p70S6K蛋白表达量明显升高,差异有统计学意义(P<0.05)。结论上调miR-1表达可增加MKN-45胃癌细胞系对AZD9291的敏感性,其作用机制可能与抑制IGF-1R/PI3K/AKT信号通路的激活有关。 Objective To investigate the effect of up-regulating or silencing of miRNA-1(miR-1)expression on the sensitivity of epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI)in gastric cancer cells in vitro.Methods Human gastric cancer cell line MKN-45 was selected as the test object.Lentivirus was transfected with miR-1 or miR-1 shRNA as miR-1 group and miR-1 shRNA group respectively.The miR-1 expression of GES-1 and MKN-45 cells was detected by real-time fluorescence quantitative PCR(qPCR).In addition,blank control group and negative control group were set.MTT assay was used to detect the sensitivity of MKN-45 cells to different concentrations of AZD9291(Osimertinib);Flow cytometry detection 1μmol/L AZD9291 on apoptosis activity and cell cycle of MKN-45 cells after 48 hours.The effects of PI3K/AKT pathway related proteins in cells of each group were detected by Western blotting.Results qPCR confirmed that miR-1 was low expressed in MKN-45 cell line.MTT assay showed that the sensitivity of miR-1 group cells to AZD9291 increased significantly,while the sensitivity of miR-1 shRNA group cells to AZD9291 decreased significantly.Annexin V/PI double staining method and BrdU method showed that the apoptosis rate of miR-1 group was(44.65±5.18)%,which was higher than that of blank control group(15.40±2.13)%and negative control group(17.92±3.14)%(P<0.05).The apoptosis rate of miR-1 shRNA group was(11.20±2.48)%,which was significantly lower than that of blank control group and negative control group(P<0.05).Compared with the blank control group and negative control group,the expression of IGF-1R,p-IGF-1R,p-AKT and p-p70S6K protein in miR-1 shRNA group decreased significantly,and the expression of IGF-1R,p-IGF-1R,p-AKT and p-p70S6K protein in miR-1 shRNA group increased significantly(P<0.05).Conclusion Up-regulating miR-1 expression can increase the sensitivity of MKN-45 gastric cancer cell line to AZD9291,and its possible mechanism is related to inhibiting the activation of IGF-1R/PI3K/AKT signaling pathway.
作者 娄智 吉亚君 王鑫 胡晨曦 刘玮萱 LOU Zhi;JI Yajun;WANG Xin;HU Chenxi;LIU Weixuan(Department of Oncology, Lianyungang First People's Hospital, Lianyungang 222000, China)
出处 《临床肿瘤学杂志》 CAS 2022年第2期103-108,共6页 Chinese Clinical Oncology
关键词 胃癌 EGFR-TKI MIR-1 AZD9291(奥西替尼) IGF-1R/PI3K/AKT信号通路 Gastric cancer EGFR-TKI miR-1 AZD9291(Osimertinib) IGF-1R/PI3K/AKT pathway
  • 相关文献

参考文献5

二级参考文献30

  • 1Ming Gao,Xiu-Ju Liang,Zi-Sen Zhang,Wang Ma,Zhi-Wei Chang,Ming-Zhi Zhang.Relationship between expression of EGFR in gastric cancer tissue and clinicopathological features[J].Asian Pacific Journal of Tropical Medicine,2013,6(4):260-264. 被引量:21
  • 2Xiang-Shan Fan,Jie-Yu Chen,Chang-Feng Li,Yi-Fen Zhang,Fan-Qing Meng,Hong-Yan Wu,An-Ning Feng,Qin Huang.Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population[J].World Journal of Gastroenterology,2013,19(21):3316-3323. 被引量:13
  • 3Yao J, Liang L, Huang S, et al. MicroRNA -30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carci- noma[ J]. Hepatology, 2010, 51 (3) : 846 - 856.
  • 4Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood - based markers for cancer detection [J].Proe Natl Acad Sei USA, 2008, 105(30) : 10513 -10518.
  • 5Chen JF, Mandel EM, Thomson JM, et al. The role of mieroRNA - 1 and microRNA - 133 in skeletal muscle proliferation and differenti-ation[J]. Nat Genet, 2006, 38(2): 228-233.
  • 6Hudson RS, Yi M, Esposito D, et al. MicroRNA - 1 is a candidate tumor suppressor and prognostic marker in human prostate cancer [J]. Nucleic Acids Res, 2012, 40(8) : 3689 -3703.
  • 7Datta J, Kutay H, Nasser MW, et al. Methylation mediated silen- cing of MicroRNA - 1 gene and its role in hepatocellular carcinogene- sis[ J]. Cancer Res, 2008, 68 (13) : 5049 - 5058.
  • 8Zhang X, Zhang E, Ma Z, et aL Modulation of hepatitis B virus rep- lication and hepatocyte differentiation by MicroRNA - 1 [ J ]. Hepa- tology, 2011, 53(5): 1476-1485.
  • 9Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742)
  • 10Terence C.Chua,Neil D.Merrett.Clinicopathologic factors associated with HER2‐positive gastric cancer and its impact on survival outcomes—A systematic review[J].Int J Cancer.2012(12)

共引文献22

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部